Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1984 Oct 1;131(7):751–755.

Phenylketonuria and its variants: observations on intellectual functioning.

C Netley, W B Hanley, H L Rudner
PMCID: PMC1483577  PMID: 6478363

Abstract

The age at diagnosis, dietary treatment and intelligence quotient (IQ) of 119 patients with phenylketonuria (PKU) and its variants who were under long-term observation were studied. In 27 of the 79 patients with classic PKU the diagnosis had been made and treatment begun late (after 2 months of age). The mean IQ of these 27 patients was 57.6 when they were in their early 20s (although 2 had normal IQs). In contrast, among the 52 patients with classic PKU who were not treated late the mean IQ was 93.6 for the 27 who were still receiving dietary therapy. The mean IQs were 99.3 and 92.7 at ages 5 (when the diet was discontinued) and 15 years respectively for the 12 who had been treated "adequately". It was 76.0 for the 13 who were "over-treated" (malnourished) in the first 6 months of life. Among the patients with atypical PKU, who were treated early, the mean IQs were 110.0 for the 7 who were still receiving dietary therapy and 102.7 for the 12 who were not. The 21 patients with persistent benign hyperphenylalaninemia, who were not treated, had a mean IQ of 104.2. The most important factor in the ultimate IQ of patients with classic PKU is very early diagnosis (by 2 weeks of age) along with immediate initiation of dietary therapy.

Full text

PDF
751

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berry H. K., O'Grady D. J., Perlmutter L. J., Bofinger M. K. Intellectual development and academic achievement of children treated early for phenylketonuria. Dev Med Child Neurol. 1979 Jun;21(3):311–320. doi: 10.1111/j.1469-8749.1979.tb01623.x. [DOI] [PubMed] [Google Scholar]
  2. Blaskovics M. E., Schaeffler G. E., Hack S. Phenylalaninaemia. Differential diagnosis. Arch Dis Child. 1974 Nov;49(11):835–843. doi: 10.1136/adc.49.11.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cabak V., Najdanvic R. Effect of undernutrition in early life on physical and mental development. Arch Dis Child. 1965 Oct;40(213):532–534. doi: 10.1136/adc.40.213.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GUTHRIE R., SUSI A. A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. Pediatrics. 1963 Sep;32:338–343. [PubMed] [Google Scholar]
  5. Güttler F., Hansen G. Different phenotypes for phenylalanine hydroxylase deficiency. Ann Clin Biochem. 1977 May;14(3):124–134. doi: 10.1177/000456327701400125. [DOI] [PubMed] [Google Scholar]
  6. Hanley W. B., Linsao L. S., Netley C. The efficacy of dietary therapy for phenylketonuria. Can Med Assoc J. 1971 Jun 19;104(12):1089–1091. [PMC free article] [PubMed] [Google Scholar]
  7. Hanley W. B., Linsao L., Davidson W., Moes C. A. Malnutrition with early treatment of phenylketonuria. Pediatr Res. 1970 Jul;4(4):318–327. doi: 10.1203/00006450-197007000-00002. [DOI] [PubMed] [Google Scholar]
  8. Kaufman S., Holtzman N. A., Milstien S., Butler L. J., Krumholz A. Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med. 1975 Oct 16;293(16):785–790. doi: 10.1056/NEJM197510162931601. [DOI] [PubMed] [Google Scholar]
  9. Kennedy J. L., Jr, Wertelecki W., Gates L., Sperry B. P., Cass V. M. The early treatment of phenylketonuria. Am J Dis Child. 1967 Jan;113(1):16–21. doi: 10.1001/archpedi.1967.02090160066004. [DOI] [PubMed] [Google Scholar]
  10. MACCREADY R. A., HUSSEY M. G. NEWBORN PHENYLKETONURIA DETECTION PROGRAM IN MASSACHUSETTS. Am J Public Health Nations Health. 1964 Dec;54:2075–2081. doi: 10.2105/ajph.54.12.2075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MacCready R. A. Admissions of phenylketonuric patients to residential institutions before and after screening programs of the newborn infant. J Pediatr. 1974 Sep;85(3):383–385. doi: 10.1016/s0022-3476(74)80124-1. [DOI] [PubMed] [Google Scholar]
  12. O'Flynn M. E., Tillman P., Hsia D. Y. Hyperphenylalanemia without phenylketonuria. Am J Dis Child. 1967 Jan;113(1):22–30. doi: 10.1001/archpedi.1967.02090160072005. [DOI] [PubMed] [Google Scholar]
  13. Williamson M. L., Koch R., Azen C., Chang C. Correlates of intelligence test results in treated phenylketonuric children. Pediatrics. 1981 Aug;68(2):161–167. [PubMed] [Google Scholar]
  14. Williamson M., Koch R., Berlow S. Diet discontinuation in phenylketonuria. Pediatrics. 1979 May;63(5):823–824. [PubMed] [Google Scholar]
  15. Woolf L. I., Goodwin B. L., Cranston W. I., Wade D. N., Woolf F., Hudson F. P., McBean M. S. A third allele at the phenylalanine-hydroxylase locus in mild phenylketonuria (hyperphenylalaninaemia). Lancet. 1968 Jan 20;1(7534):114–117. doi: 10.1016/s0140-6736(68)92722-0. [DOI] [PubMed] [Google Scholar]
  16. Yu J. S., Stuckey S. J., O'Halloran M. T. Atypical phenylketonuria. An approach to diagnosis and management. Arch Dis Child. 1970 Aug;45(242):561–565. doi: 10.1136/adc.45.242.561. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES